{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:08Z","timestamp":1786118888274,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/mnh.0b013e3282f49566","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T03:01:20Z","timestamp":1202871680000},"page":"199-204","source":"Crossref","is-referenced-by-count":25,"title":["Urotensin II: a cardiovascular and renal update"],"prefix":"10.1097","volume":"17","author":[{"given":"Zoccali","family":"Carmine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210206","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.ki.5001621","article-title":"Renal and vascular actions of urotensin II","volume":"70","author":"Ashton","year":"2006","journal-title":"Kidney Int"},{"key":"R2-14-20210206","first-page":"205","article-title":"Characterization of the biologically and antigenically important regions of urotensin II","volume":"29","author":"McMaster","year":"1986","journal-title":"Proc West Pharmacol Soc"},{"key":"R3-14-20210206","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0014-5793(90)81500-N","article-title":"Posttranslational processing of prepro-urotensin II","volume":"266","author":"Conlon","year":"1990","journal-title":"FEBS Lett"},{"key":"R4-14-20210206","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.peptides.2005.03.043","article-title":"Urotensin II: evidence for cardiac, hepatic and renal production","volume":"26","author":"Charles","year":"2005","journal-title":"Peptides"},{"key":"R5-14-20210206","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbrc.2003.09.102","article-title":"Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain","volume":"310","author":"Sugo","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R6-14-20210206","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/45809","article-title":"Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14","volume":"401","author":"Ames","year":"1999","journal-title":"Nature"},{"key":"R7-14-20210206","doi-asserted-by":"crossref","first-page":"H925","DOI":"10.1152\/ajpheart.2001.280.2.H925","article-title":"Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries","volume":"280","author":"Stirrat","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R9-14-20210206","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.peptides.2004.04.017","article-title":"Urotensin II in the cardiovascular system","volume":"25","author":"Richards","year":"2004","journal-title":"Peptides"},{"key":"R10-14-20210206","doi-asserted-by":"crossref","first-page":"H348","DOI":"10.1152\/ajpheart.00512.2006","article-title":"Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction","volume":"292","author":"Wang","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R11-14-20210206","first-page":"284","article-title":"Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by urotensin I, a selective mesenteric vasodilator peptide","volume":"242","author":"Bolt","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-14-20210206","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0196-9781(02)00104-3","article-title":"Cardiovascular effects of urotensin II in different brain areas","volume":"23","author":"Lu","year":"2002","journal-title":"Peptides"},{"key":"R13-14-20210206","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(01)03015-0","article-title":"Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats","volume":"508","author":"Zou","year":"2001","journal-title":"FEBS Lett"},{"key":"R14-14-20210206","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bjp.0704924","article-title":"Is urotensin-II the new endothelin?","volume":"137","author":"Maguire","year":"2002","journal-title":"Br J Pharmacol"},{"key":"R15-14-20210206","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.bjp.0703811","article-title":"Cardiostimulant effects of urotensin-II in human heart in vitro","volume":"132","author":"Russell","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R16-14-20210206","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1152\/japplphysiol.00540.2004","article-title":"Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat","volume":"97","author":"Gong","year":"2004","journal-title":"J Appl Physiol"},{"key":"R17-14-20210206","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.peptides.2004.03.029","article-title":"Cardiovascular role of urotensin II: effect of chronic infusion in the rat","volume":"25","author":"Kompa","year":"2004","journal-title":"Peptides"},{"key":"R18-14-20210206","doi-asserted-by":"crossref","first-page":"H830","DOI":"10.1152\/ajpheart.00406.2003","article-title":"Urotensin II causes fatal circulatory collapse in anesthesized monkeys in vivo: a \u2018vasoconstrictor\u2019 with a unique hemodynamic profile","volume":"286","author":"Zhu","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R19-14-20210206","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.RES.0000084382.64418.BC","article-title":"Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy","volume":"93","author":"Tzanidis","year":"2003","journal-title":"Circ Res"},{"key":"R20-14-20210206","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0140-6736(02)08831-1","article-title":"Congestive heart failure and expression of myocardial urotensin II","volume":"359","author":"Douglas","year":"2002","journal-title":"Lancet"},{"key":"R21-14-20210206","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1161\/01.CIR.0000044388.19119.02","article-title":"Plasma urotensin in human systolic heart failure","volume":"106","author":"Ng","year":"2002","journal-title":"Circulation"},{"key":"R22-14-20210206","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(02)09709-X","article-title":"Plasma urotensin II in heart failure","volume":"360","author":"Richards","year":"2002","journal-title":"Lancet"},{"key":"R23-14-20210206","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.regpep.2004.04.012","article-title":"The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease","volume":"121","author":"Heringlake","year":"2004","journal-title":"Regul Pept"},{"key":"R24-14-20210206","doi-asserted-by":"crossref","first-page":"H1576","DOI":"10.1152\/ajpheart.00217.2003","article-title":"Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure","volume":"285","author":"Russell","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R25-14-20210206","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.peptides.2007.04.018","article-title":"Hemodynamic effects of chronic urotensin II administration in animals with and without aorto-caval fistula","volume":"28","author":"Harris","year":"2007","journal-title":"Peptides"},{"key":"R27-14-20210206","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/002215540205000702","article-title":"Localization of urotensin-II immunoreactivity in normal human kidneys and renal carcinoma","volume":"50","author":"Shenouda","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"R28-14-20210206","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/sj.ki.5000290","article-title":"Urotensin II and renal function in the rat","volume":"69","author":"Song","year":"2006","journal-title":"Kidney Int"},{"key":"R29-14-20210206","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/ndt\/gfk049","article-title":"Renal effects of human urotensin-II in rats with experimental congestive heart failure","volume":"21","author":"Ovcharenko","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R30-14-20210206","doi-asserted-by":"crossref","first-page":"F792","DOI":"10.1152\/ajprenal.00342.2002","article-title":"Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney","volume":"285","author":"Zhang","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"R31-14-20210206","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tips.2003.12.005","article-title":"From \u2018gills to pills\u2019: urotensin-II as a regulator of mammalian cardiorenal function","volume":"25","author":"Douglas","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"R33-14-20210206","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.peptides.2004.06.024","article-title":"Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy","volume":"25","author":"Totsune","year":"2004","journal-title":"Peptides"},{"key":"R34-14-20210206","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.hjh.0000125452.28861.f1","article-title":"Plasma concentration of urotensin II is raised in hypertension","volume":"22","author":"Cheung","year":"2004","journal-title":"J Hypertens"},{"key":"R35-14-20210206","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(01)06002-0","article-title":"Role of urotensin II in patients on dialysis","volume":"358","author":"Totsune","year":"2001","journal-title":"Lancet"},{"key":"R36-14-20210206","first-page":"727","article-title":"Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides","volume":"18","author":"Mallamaci","year":"2005","journal-title":"J Nephrol"},{"key":"R37-14-20210206","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0272-6386(04)01130-8","article-title":"Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy","volume":"44","author":"Langham","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R38-14-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00467-004-1716-5","article-title":"Urotensin-II levels in children with minimal change nephrotic syndrome","volume":"20","author":"Balat","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R39-14-20210206","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.peptides.2004.05.015","article-title":"Differential levels of \u2018urotensin-II-like\u2019 activity determined by radio-receptor and radioimmuno-assays","volume":"25","author":"Aiyar","year":"2004","journal-title":"Peptides"},{"key":"R40-14-20210206","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2003.05.008","article-title":"Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy","volume":"94","author":"Lapp","year":"2004","journal-title":"Int J Cardiol"},{"key":"R41-14-20210206","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.peptides.2005.11.019","article-title":"Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers","volume":"27","author":"Gruson","year":"2006","journal-title":"Peptides"},{"key":"R42-14-20210206","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/bbrc.2001.5946","article-title":"Flow-induced pressure differentially regulates endothelin-1, urotensin II, adrenomedullin, and relaxin in pulmonary vascular endothelium","volume":"289","author":"Dschietzig","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R43-14-20210206","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijcard.2005.04.001","article-title":"Urotensin-II levels in acute coronary syndromes","volume":"108","author":"Joyal","year":"2006","journal-title":"Int J Cardiol"},{"key":"R44-14-20210206","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/sj.ki.5000114","article-title":"Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease","volume":"69","author":"Zoccali","year":"2006","journal-title":"Kidney Int"},{"key":"R45-14-20210206","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijcard.2006.05.016","article-title":"Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans","volume":"117","author":"Khan","year":"2007","journal-title":"Int J Cardiol"},{"key":"R46-14-20210206","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/08860220701392108","article-title":"Urotensin-II immunoreactivity in children with chronic glomerulonephritis","volume":"29","author":"Balat","year":"2007","journal-title":"Ren Fail"},{"key":"R47-14-20210206","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.amjhyper.2005.10.019","article-title":"Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease","volume":"19","author":"Mallamaci","year":"2006","journal-title":"Am J Hypertens"},{"key":"R50-14-20210206","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.clpt.2006.05.013","article-title":"Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients","volume":"80","author":"Sidharta","year":"2006","journal-title":"Clin Pharmacol Ther"}],"container-title":["Current Opinion in Nephrology & Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNH.0b013e3282f49566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:50:51Z","timestamp":1786035051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041552-200803000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mnh.0b013e3282f49566","relation":{},"ISSN":["1062-4821"],"issn-type":[{"value":"1062-4821","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}